Home > Corey Cutler, ASH 2019: Evolving Treatment for Patients with GvHD

Corey Cutler, ASH 2019: Evolving Treatment for Patients with GvHD

Published Online: December 18th 2019

At the 61st ASH Annual Meeting & Exposition, Corey Cutler, Dana Farber Cancer Institute, discusses his presentation: The Evolving Treatment Landscape for Patients with GvHD: More Options, More Decisions, Better Outcomes!


1. What are the major challenges in the treatment of patients with graft-versus-host disease (GvHD)? (0:05)

2. How have recent advances in understanding of the biology of GvHD impacted on patient management? (0:45)

3. What do you consider the most important emerging therapies for GvHD? (1:22)

4. What do healthcare professionals need to know in terms of monitoring and appropriate management of treatment-related adverse events? (1:54)

5. What other key messages of this symposium would you like to highlight? (2:33)


Corey Cutler has no conflicts of interest to declare in relation to this video.

Filmed at the 61st ASH Annual Meeting & Exposition 2019, Orlando, FL, USA.



Share this Video
Related Videos In Haematology
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar